Search
Now showing items 1-10 of 19
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
(Elsevier, 2015)
This paper empirically examines the consumer welfare implications of changes in government policies related to patent protection and compulsory licensing in the Indian market for oral anti-diabetic (OAD) medicines. In ...
When the big one came: a natural experiment on demand shock and market structure in India’s influenza vaccine markets
(John Wiley, 2018-08)
This paper examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines ...
Did India’s price control policy for coronary stents create unintended consequences?
(Social Science & Medicine, 2020)
In February 2017, India capped the retail price of coronary stents and restricted the channel margin to bring Percutaneous Transluminal Coronary Angioplasty (PTCA) procedure, which uses coronary stents, within reach of ...
From courts to markets: new evidence on enforcement of pharmaceutical bans in India
(Social Science & Medicine, 2019)
Regulatory enforcement of product safety standards given health concerns, whether it is in romaine lettuce, smartphones or cars, is emerging to be a challenge for global public health. This is particularly true for developing ...
Competition law in india: perspectives
(Sage, 2016)
In 2002, the Parliament of India enacted the Competition Act, replacing the
archaic Monopoly and Restrictive Trade Practices Act (popularly referred to as
the MRTP Act) of 1969. The primary goal of the Act, as stated in ...
Crocin or paracetamol: what should the doctor prescribe?
(Economic & Political Weekly, 2013)
As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes ...
Balancing affordability and availability in a drug patent regime
(Economic and Political Weekly, 2015)
India needs to fi
nd an optimal
patenting regime that will
safeguard incentives for
innovation while simultaneously
ensuring that medicines are
available at reasonable prices.
The Welfare Implications of Patent Protection, Pricing and Licensing in the Indian Oral Anti-Diabetic Market
(Indian Institute of Management Ahmedabad, 2013)
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 ...
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
(Research Policy, 2020-09-12)
We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and ...
Intellectual property regimes and wage inequality
(Elsevier, 2021-07-19)
We use The Patents (Amendment) Act, 2002 in India as a quasi-natural experiment to identify the causal effect of higher incentives for innovation on a firm’s compensation structure. We find that stronger intellectual ...